Publications
- Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study2023 | First Faculty of Medicine
- Acute Medication Use in Patients With Migraine Treated With Monoclonal Antibodies Acting on the CGRP Pathway: Results From a Multicenter Study and Proposal of a New Index2022 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study2022 | First Faculty of Medicine, Faculty of Physical Education and Sport
- CGRP antibodies in the prophylactic treatment of migraine2022 | First Faculty of Medicine
- Opinion of the Section for headache diagnosis and treatment of the Czech Neurological Society CLS JEP on the staff and technical equipment of the headache diagnostic and treatment centers and on the organization way of their sites focusing on the biological treatment of migraine2022 | First Faculty of Medicine
- Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men2021 | First Faculty of Medicine, Central Library of Charles University
- CGRP monoclonal antibodies in the treatment of migraine - indication criteria and therapeutic recommendations for the Czech Republic2020 | First Faculty of Medicine, Third Faculty of Medicine
- Migraine - current treatment options2020 | First Faculty of Medicine
- Fremanezumab in migraine treatment - optimal patient selection2020 | First Faculty of Medicine
- Socio-economic impact of headache disorders - reasons and improvement possibilities2020 | First Faculty of Medicine
Loading network view...